Home Go to http://www.treatHIV.com
Test Information HomeBoardAboutContact
 

Perspectives and OpinionsMutation and Drug DataAsk the ExpertsTest InfoFrom the PodiumDaily Resistance NewsBest of SiteArchive
Applied Biosystems (formerly PE Biosystems)

Contacts
For clinical information:
Dr. Suzanne Coberly
Clinical Affairs, Applied Biosystems
(650) 638-2263
coberlsk@appliedbiosystems.com

To order tests or for other information:
Leila Smith
Product Manager, Applied Biosystems
(650) 638-6443
smithlg@appliedbiosystems.com


Applied Biosystems Group, formerly PE Biosystems Group, changed its name when its parent company, PE Corporation, became Applera Corporation. This new name is a combination of the names of the company’s two operating businesses, the Applied Biosystems Group and the Celera Genomics Group.

Applied Biosystems is a manufacturer of a kit-based sequencing assay. This kit is currently commercialized as a Research Use Only assay.


GENERAL INFORMATION

Assay Names ViroSeq™ HIV-1 Genotyping System
Collaborators/Distributors RDL, Contra Costa County Public Health Laboratory
Availability Commercially available for research use only.
Regulatory Status For "Investigational Use Only" under an FDA-approved IDE in CLIA certified labs. Applied Biosystems is a CLIA certified laboratory.
Proficiency Testing Programs Content in development.
Clinical Trials Content in development.
Financial Assistance No


ASSAY INFORMATION

Genotypic Codons Interrogated Turnaround time Sensitivity
RT PI
Full sequencing assay 1–320 1–99 Variable 500 RNA copies/mL


METHODOLOGY
Viral RNA is extracted from plasma and amplified through RT-PCR. The products undergo dye terminator sequencing. ViroSeq HIV-1 Genotyping System uses DNA Sequencing technology: the entire protease gene and the first 320 codons of the reverse transcriptase gene are sequenced to identify the HIV-1 mutations. ViroSeq system software is then used to compare the sequences with wild type viral sequences (HXB2) and against a database of known resistance mutations to determine the resistance mutations.


REPORT INFORMATION

Report Drug Resistance Interpretation
Genotype Yes Currently, the report and interpretation are based on HIV-1 mutations that are known to be associated to drug resistance. Additional content in development.


Return to Test Information Table - Genotypic

Return to Test Information Table - Phenotypic


  Vertibrae
Copyright © 1997–2003, Vertibrae, Inc. and HIVresistanceWeb. All rights reserved.  |  Privacy Policy
RegisterLogin